|
Arterial thrombosis
Citations 251-260 of 336 total displayed.
|
Past content
(since Oct 2000):
|
- Clinical Investigations and Reports
C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis
- Sridevi Devaraj, Dan Yan Xu, and Ishwarlal Jialal
Circulation 2003;107:398-404; published online before print as doi:10.1161/01.CIR.0000052617.91920.FD
[Abstract]
[Full text]
- Images in Cardiovascular Medicine
Thromboembolism in Real-Time Two-Dimensional Echocardiography
- Gershan K. Davis, Clive Fisk, and Sandeep Talwar
Circulation 2003;107:e1, doi:10.1161/01.CIR.0000046072.10311.41
[Full text]
- Clinical Investigations and Reports
C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis
- Sridevi Devaraj, Dan Yan Xu, and Ishwarlal Jialal
Circulation published January 6, 2003, doi:10.1161/01.CIR.0000052617.91920.FD
[Abstract]
[Full text]
- Correspondence
Aspirin Resistance • Aspirin Resistance • Response
- Jorge Rouvier, Alejandra Scazziota, Raúl Altman, Jonathan D. Smout, Gerard Stansby, John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz, Marilyn Johnston, Qilong Yi, and Salim Yusuf
Circulation 2002;106:e200-201e, doi:10.1161/01.CIR.0000041810.21243.DB
[Full text]
- Correspondence
Reasons for Resistance to Aspirin in Cardiovascular Disease • Response
- A. Szczeklik, J. Musia
 , A. Undas, John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz, Marilyn Johnston, Qilong Yi, and Salim Yusuf
Circulation 2002;106:e181-182e, doi:10.1161/01.CIR.0000037294.28723.DA
[Full text]
- Cardiology Patient Pages
Treatment of Blood Clots
- Samuel Z. Goldhaber and Nicole Grasso-Correnti
Circulation 2002;106:e138-140e, doi:10.1161/01.CIR.0000038923.61628.3D
[Full text]
- Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
- Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation 2002;106:2550-2554; published online before print as doi:10.1161/01.CIR.0000038501.87442.02
[Abstract]
[Full text]
- Correspondence
Safety of C1-Inhibitor for Clinical Use • Response
- C. Erik Hack, Chris de Zwaan, Wim T. Hermens, Georg Horstick, Oliver Berg, Benjamin Bierbach, Steffen Petersen, Harald Darius, Marina Horstick, Jürgen Meyer, Axel Heimann, Oliver Kempski, Otto Götze, Michael Loos, Sucharit Bhakdi, and Gerd Hafner
Circulation 2002;106:e132, doi:10.1161/01.CIR.0000035928.78148.CB
[Full text]
- Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the
Anticoagulant Effect of the Pentasaccharide Fondaparinux in
Healthy Volunteers
- Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation published October 21, 2002, doi:10.1161/01.CIR.0000038501.87442.02
[Abstract]
- Clinical Investigations and Reports
Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease
- Joseph D. Mills, Robert A.S. Ariëns, Michael W. Mansfield, and Peter J. Grant
Circulation 2002;106:1938-1942; published online before print as doi:10.1161/01.CIR.0000033221.73082.06
[Abstract]
[Full text]
|
|
